查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1704276

2025年內分泌檢測全球市場報告

Endocrine Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年內分泌檢測市場規模將強勁成長。到 2029 年，這一數字將成長至 40.1 億美元，複合年成長率為 9.5%。預測期內的成長可歸因於內分泌失調盛行率的增加、國防支出的增加、人口老化以及認知的提高和早期診斷。預測期內的關鍵趨勢包括生物標記檢測的進步、體學技術的整合、人工智慧和機器學習、品質保證和標準化、合作研究和轉化醫學。

糖尿病盛行率的不斷上升預計將推動內分泌檢測市場的成長。糖尿病是一組以高血糖（葡萄糖）水平為特徵的疾病，由於不良飲食、久坐的生活方式、遺傳因素和衰老等因素，其盛行率正在增加。內分泌測試，包括糖化血紅蛋白、空腹血糖和 C 肽等測試，對於診斷糖尿病、監測血糖濃度以及評估胰島素的產生和敏感性至關重要。例如，2024年6月，英國國家醫療服務體系（NHS）報告稱，40歲以下糖尿病患者數量顯著增加，從2022年的173,166人增加到2023年的216,440人。這一急劇成長代表著年輕族群糖尿病盛行率令人擔憂的趨勢。因此，糖尿病盛行率的不斷上升刺激了對內分泌檢測解決方案的需求。

內分泌檢測市場的關鍵參與者正致力於開發就地檢驗解決方案，以提高診斷內分泌疾病的可及性和效率。就地檢驗可以快速得出結果，有助於快速診斷和治療出現呼吸急促和疲勞等症狀的患者的心臟衰竭等疾病。例如，2024 年 4 月，瑞士製藥公司羅氏控股公司在印度推出了照護現場NT-proBNP 檢測。該測試專門用於篩檢患有心血管疾病（包括心臟衰竭（HF））風險的糖尿病患者，以便早期發現和早期療育。該測試將使臨床醫生能夠快速識別高風險的第 2 型糖尿病患者並及時開始治療，最終改善治療結果和患者的健康。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球內分泌測試PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球內分泌檢測市場：成長率分析
  • 全球內分泌檢測市場表現：規模與成長，2019-2024
  • 全球內分泌檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球內分泌檢測總目標市場（TAM）

第6章市場區隔

  • 全球內分泌檢測市場（按檢測類型、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 雌二醇（E2）測試
  • 濾泡刺激素（FSH）檢測
  • 人類絨毛膜促性腺激素分泌(hCG) 檢測
  • 黃體激素（LH）測試
  • 脫氫表雄酮硫酸鹽（DHEAS）測試
  • 黃體酮檢測
  • 睪酮測試
  • 甲狀腺刺激素（TSH）檢測
  • 催乳素檢測
  • 其他類型
  • 全球內分泌檢測市場（依技術、效能和預測）：2019-2024 年、2024-2029 年、2034 年
  • 串聯式質譜質譜法
  • 免疫檢測
  • 單株和多株抗體技術
  • 感測器技術
  • 臨床化學
  • 其他技術
  • 全球內分泌檢測市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 臨床實驗室
  • 診斷中心
  • 其他最終用戶
  • 全球內分泌檢測市場雌二醇（E2）檢測細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 血清雌二醇檢測
  • 尿雌二醇檢測
  • 全球內分泌檢測市場濾泡刺激素(FSH) 檢測細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • FSH血清檢測
  • FSH尿液檢查
  • 全球內分泌檢測市場人類絨毛膜促性腺激素分泌(hCG) 檢測細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 定量hCG檢測
  • 定性 hCG 檢測
  • 全球內分泌檢測市場黃體激素(LH) 檢測細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • LH血清檢測
  • LH尿液檢查
  • 全球內分泌檢測市場脫氫表雄酮硫酸鹽 (DHEAS) 檢測細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 血清DHEAS檢測
  • 唾液脫氫表雄酮檢測
  • 全球內分泌檢測市場孕酮檢測細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 血清黃體素檢測
  • 尿液孕酮檢測
  • 全球內分泌檢測市場區隔（依睪固酮檢測類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 免費睪固酮測試
  • 總睾酮測試
  • 全球內分泌檢測市場甲狀腺刺激素(TSH) 檢測細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • TSH血清檢測
  • TSH唾液檢測
  • 全球內分泌檢測市場，依催乳素檢測類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血清催乳素檢測
  • 血漿催乳素檢測
  • 全球內分泌檢測市場，按類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 皮質醇測試
  • 胰島素檢測
  • 生長激素（GH）測試
  • 醛固酮測試

第7章 區域和國家分析

  • 全球內分泌檢測市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球內分泌檢測市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 內分泌檢測市場：競爭格局
  • 內分泌檢測市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Roche Holding Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • BioMerieux SA
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • SD Biosensor Inc.
  • Qiagen NV
  • Ortho Clinical Diagnostics
  • Kronus Inc.
  • Randox Laboratories Ltd.
  • Fujirebio Diagnostics Inc.
  • Inova Diagnostics Inc.
  • Sekisui Diagnostics LLC
  • Mercodia AB
  • ZEUS Scientific Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年內分泌檢測市場：提供新機會的國家
  • 2029年內分泌檢測市場：細分領域帶來新機會
  • 2029年內分泌檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r30136

Endocrine testing involves the diagnostic assessment of hormone levels within the body, typically conducted through blood, urine, or saliva analyses, to evaluate the function of the endocrine system. These tests play a vital role in diagnosing a range of endocrine disorders, such as diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders, enabling healthcare providers to formulate appropriate treatment and management plans for affected patients.

The primary types of endocrine testing encompass various assessments including the estradiol (E2) test, follicle-stimulating hormone (FSH) test, human chorionic gonadotropin (HCG) hormone test, luteinizing hormone (LH) test, dehydroepiandrosterone sulfate (DHEAS) test, progesterone test, testosterone test, thyroid-stimulating hormone (TSH) test, prolactin test, among others. For instance, the Estradiol (E2) Test involves a blood test to measure estradiol levels in the body. These tests utilize diverse technologies such as tandem mass spectrometry, immunoassays, monoclonal and polyclonal antibody technologies, sensor technology, clinical chemistry, among others, and are commonly conducted in hospitals, clinical laboratories, diagnostic centers, and similar healthcare facilities.

The endocrine testing market research report is one of a series of new reports from The Business Research Company that provides endocrine testing market statistics, including endocrine testing industry global market size, regional shares, competitors with a endocrine testing market share, detailed endocrine testing market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine testing industry. This endocrine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.8 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment.

The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing prevalence of endocrine disorders, increased defense spending, aging population, awareness and early diagnosis, and increased awareness. Major trends in the forecast period include advancements in biomarker detection, integration of omics technologies, artificial intelligence and machine learning, quality assurance and standardization, and collaborative research and translational medicine.

The increasing prevalence of diabetes is expected to drive the growth of the endocrine testing market. Diabetes is a group of diseases characterized by high blood sugar (glucose) levels, and its prevalence is rising due to factors such as poor dietary habits, sedentary lifestyles, genetic factors, and an aging population. Endocrine testing, including tests like hemoglobin A1c, fasting plasma glucose, and C-peptide, is essential in diagnosing diabetes, monitoring glucose levels, and evaluating insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS) reported a significant increase in diabetes cases among individuals under 40, with the number rising from 173,166 in 2022 to 216,440 in 2023. This surge indicates a concerning trend in diabetes prevalence among younger populations. As a result, the growing prevalence of diabetes is fueling the demand for endocrine testing solutions.

Key players in the endocrine testing market are focusing on developing point-of-care testing solutions to enhance accessibility and efficiency in diagnosing endocrine disorders. Point-of-care testing enables rapid results, aiding in prompt diagnosis and management of conditions such as heart failure in patients displaying symptoms such as shortness of breath and fatigue. For example, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced a point-of-care NT-proBNP test in India. This test is specifically tailored for screening diabetes patients at risk of cardiovascular diseases such as heart failure (HF), facilitating early detection and intervention. It empowers clinicians to identify high-risk T2D patients promptly and initiate timely treatment discussions, ultimately leading to improved outcomes and patient well-being.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics, although the financial details remain undisclosed. This acquisition aligns with Tolmar's focus on pediatric endocrinology and men's health, augmenting their portfolio of specialty pharmaceutical products. Clarus Therapeutics, a US-based pharmaceutical company, specializes in developing and commercializing therapies for individuals with endocrine disorders.

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine testing market consists of revenues earned by entities by providing services such as hormone level testing, thyroid function testing, diabetes testing, adrenal function testing, reproductive hormone testing, pituitary function testing, and bone metabolism testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine testing market also includes sales of assay kits, analyzers, point-of-care testing devices, reagents, software solutions, quality control materials, and calibrators and controls. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
  • 2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
  • 3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users
  • Subsegments:
  • 1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test
  • 2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test
  • 3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test
  • 4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test
  • 5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test
  • 6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test
  • 7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test
  • 8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test
  • 9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test
  • 10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Roche Holding; Siemens Healthineers; Quest Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Testing Market Characteristics

3. Endocrine Testing Market Trends And Strategies

4. Endocrine Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Endocrine Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Endocrine Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Endocrine Testing Market Growth Rate Analysis
  • 5.4. Global Endocrine Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Endocrine Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Endocrine Testing Total Addressable Market (TAM)

6. Endocrine Testing Market Segmentation

  • 6.1. Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Hormone Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone Sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Other Types
  • 6.2. Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal And Polyclonal Antibody Technologies
  • Sensor Technology
  • Clinical Chemistry
  • Other Technologies
  • 6.3. Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical Laboratories
  • Diagnostic Centers
  • Other End-Users
  • 6.4. Global Endocrine Testing Market, Sub-Segmentation Of Estradiol (E2) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Estradiol Test
  • Urinary Estradiol Test
  • 6.5. Global Endocrine Testing Market, Sub-Segmentation Of Follicle Stimulating Hormone (FSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • FSH Serum Test
  • FSH Urine Test
  • 6.6. Global Endocrine Testing Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG) Hormone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantitative hCG Test
  • Qualitative hCG Test
  • 6.7. Global Endocrine Testing Market, Sub-Segmentation Of Luteinizing Hormone (LH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • LH Serum Test
  • LH Urine Test
  • 6.8. Global Endocrine Testing Market, Sub-Segmentation Of Dehydroepiandrosterone Sulfate (DHEAS) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum DHEAS Test
  • Saliva DHEAS Test
  • 6.9. Global Endocrine Testing Market, Sub-Segmentation Of Progesterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Progesterone Test
  • Urinary Progesterone Test
  • 6.10. Global Endocrine Testing Market, Sub-Segmentation Of Testosterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Free Testosterone Test
  • Total Testosterone Test
  • 6.11. Global Endocrine Testing Market, Sub-Segmentation Of Thyroid Stimulating Hormone (TSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • TSH Serum Test
  • TSH Saliva Test
  • 6.12. Global Endocrine Testing Market, Sub-Segmentation Of Prolactin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Prolactin Test
  • Plasma Prolactin Test
  • 6.13. Global Endocrine Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cortisol Test
  • Insulin Test
  • Growth Hormone (GH) Test
  • Aldosterone Test

7. Endocrine Testing Market Regional And Country Analysis

  • 7.1. Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endocrine Testing Market

  • 8.1. Asia-Pacific Endocrine Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endocrine Testing Market

  • 9.1. China Endocrine Testing Market Overview
  • 9.2. China Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endocrine Testing Market

  • 10.1. India Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endocrine Testing Market

  • 11.1. Japan Endocrine Testing Market Overview
  • 11.2. Japan Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endocrine Testing Market

  • 12.1. Australia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endocrine Testing Market

  • 13.1. Indonesia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endocrine Testing Market

  • 14.1. South Korea Endocrine Testing Market Overview
  • 14.2. South Korea Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endocrine Testing Market

  • 15.1. Western Europe Endocrine Testing Market Overview
  • 15.2. Western Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endocrine Testing Market

  • 16.1. UK Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endocrine Testing Market

  • 17.1. Germany Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endocrine Testing Market

  • 18.1. France Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endocrine Testing Market

  • 19.1. Italy Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endocrine Testing Market

  • 20.1. Spain Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endocrine Testing Market

  • 21.1. Eastern Europe Endocrine Testing Market Overview
  • 21.2. Eastern Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endocrine Testing Market

  • 22.1. Russia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endocrine Testing Market

  • 23.1. North America Endocrine Testing Market Overview
  • 23.2. North America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endocrine Testing Market

  • 24.1. USA Endocrine Testing Market Overview
  • 24.2. USA Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endocrine Testing Market

  • 25.1. Canada Endocrine Testing Market Overview
  • 25.2. Canada Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endocrine Testing Market

  • 26.1. South America Endocrine Testing Market Overview
  • 26.2. South America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endocrine Testing Market

  • 27.1. Brazil Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endocrine Testing Market

  • 28.1. Middle East Endocrine Testing Market Overview
  • 28.2. Middle East Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endocrine Testing Market

  • 29.1. Africa Endocrine Testing Market Overview
  • 29.2. Africa Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endocrine Testing Market Competitive Landscape And Company Profiles

  • 30.1. Endocrine Testing Market Competitive Landscape
  • 30.2. Endocrine Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Roche Holding Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

31. Endocrine Testing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. PerkinElmer Inc.
  • 31.3. BioMerieux SA
  • 31.4. Beckman Coulter Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. SD Biosensor Inc.
  • 31.7. Qiagen N.V.
  • 31.8. Ortho Clinical Diagnostics
  • 31.9. Kronus Inc.
  • 31.10. Randox Laboratories Ltd.
  • 31.11. Fujirebio Diagnostics Inc.
  • 31.12. Inova Diagnostics Inc.
  • 31.13. Sekisui Diagnostics LLC
  • 31.14. Mercodia AB
  • 31.15. ZEUS Scientific Inc.

32. Global Endocrine Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endocrine Testing Market

34. Recent Developments In The Endocrine Testing Market

35. Endocrine Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Endocrine Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Endocrine Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Endocrine Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer